ChenGuang Biotech Group Co., Ltd. (SHE:300138)
China
· Delayed Price · Currency is CNY 11.69
+0.32 (2.81%)
Apr 29, 2026, 3:04 PM CST
ChenGuang Biotech Group Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 5,647 | 5,995 | 4,213 | 7,155 | 9,446 | 8,897 | Upgrade
|
| Market Cap Growth | 22.67% | 42.32% | -41.13% | -24.25% | 6.17% | -3.52% | Upgrade
|
| Enterprise Value | 8,921 | 7,749 | 5,744 | 8,149 | 10,035 | 9,439 | Upgrade
|
| Last Close Price | 11.69 | 12.41 | 8.62 | 13.08 | 17.11 | 15.98 | Upgrade
|
| PE Ratio | 15.86 | 16.25 | 44.79 | 14.92 | 21.76 | 25.31 | Upgrade
|
| Forward PE | 12.88 | 12.82 | 14.75 | 12.05 | 17.63 | 21.67 | Upgrade
|
| PS Ratio | 0.87 | 0.91 | 0.60 | 1.04 | 1.50 | 1.83 | Upgrade
|
| PB Ratio | 1.60 | 1.74 | 1.34 | 2.03 | 2.94 | 3.20 | Upgrade
|
| P/TBV Ratio | 1.79 | 1.96 | 1.52 | 2.26 | 3.31 | 3.53 | Upgrade
|
| P/FCF Ratio | - | 77.21 | - | - | 16.91 | - | Upgrade
|
| P/OCF Ratio | - | 28.16 | - | - | 12.86 | 139.24 | Upgrade
|
| EV/Sales Ratio | 1.38 | 1.18 | 0.82 | 1.19 | 1.59 | 1.94 | Upgrade
|
| EV/EBITDA Ratio | 14.93 | 13.03 | 19.75 | 12.87 | 16.91 | 18.52 | Upgrade
|
| EV/EBIT Ratio | 21.74 | 18.80 | 46.28 | 16.95 | 22.36 | 24.90 | Upgrade
|
| EV/FCF Ratio | -50.44 | 99.80 | - | - | 17.96 | - | Upgrade
|
| Debt / Equity Ratio | 1.88 | 1.49 | 1.56 | 1.19 | 0.88 | 0.88 | Upgrade
|
| Debt / EBITDA Ratio | 11.06 | 8.60 | 16.88 | 6.66 | 4.75 | 4.80 | Upgrade
|
| Debt / FCF Ratio | - | 65.96 | - | - | 5.04 | - | Upgrade
|
| Net Debt / Equity Ratio | 0.91 | 1.05 | 0.98 | 0.76 | 0.51 | 0.61 | Upgrade
|
| Net Debt / EBITDA Ratio | 5.40 | 6.05 | 10.62 | 4.26 | 2.77 | 3.35 | Upgrade
|
| Net Debt / FCF Ratio | -18.21 | 46.35 | -8.29 | -3.47 | 2.94 | -7.87 | Upgrade
|
| Asset Turnover | 0.61 | 0.71 | 0.80 | 0.89 | 0.98 | 0.92 | Upgrade
|
| Inventory Turnover | 1.51 | 1.42 | 1.85 | 2.32 | 2.56 | 2.08 | Upgrade
|
| Quick Ratio | 0.54 | 0.37 | 0.50 | 0.51 | 0.57 | 0.43 | Upgrade
|
| Current Ratio | 1.24 | 1.29 | 1.48 | 1.61 | 1.79 | 1.48 | Upgrade
|
| Return on Equity (ROE) | 10.67% | 11.37% | 2.33% | 14.65% | 14.54% | 14.48% | Upgrade
|
| Return on Assets (ROA) | 2.40% | 2.78% | 0.88% | 3.89% | 4.35% | 4.47% | Upgrade
|
| Return on Invested Capital (ROIC) | 5.13% | 5.32% | 1.45% | 7.71% | 8.35% | 8.03% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.80% | 11.10% | 2.80% | 10.50% | 10.80% | 11.60% | Upgrade
|
| Earnings Yield | 6.31% | 6.15% | 2.23% | 6.71% | 4.59% | 3.95% | Upgrade
|
| FCF Yield | -3.13% | 1.29% | -8.84% | -10.87% | 5.92% | -2.44% | Upgrade
|
| Dividend Yield | 2.64% | 2.42% | 1.51% | 0.99% | 0.94% | 0.81% | Upgrade
|
| Payout Ratio | 47.02% | 43.34% | 185.07% | 37.82% | 33.17% | 31.23% | Upgrade
|
| Buyback Yield / Dilution | 4.35% | 6.62% | 2.76% | 0.14% | -0.80% | -4.13% | Upgrade
|
| Total Shareholder Return | 6.93% | 9.04% | 4.27% | 1.13% | 0.13% | -3.31% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.